🇺🇸 FDA
Pipeline program

PDI-320

172-7451-201

Phase 2 small_molecule active

Quick answer

PDI-320 for Rosacea is a Phase 2 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Rosacea
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials